These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29923200)

  • 1. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.
    Chim SM; Kuek V; Chow ST; Lim BS; Tickner J; Zhao J; Chung R; Su YW; Zhang G; Erber W; Xian CJ; Rosen V; Xu J
    J Cell Physiol; 2015 Jan; 230(1):82-94. PubMed ID: 24909139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma.
    Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q
    Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
    Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
    Xu HF; Chen L; Liu XD; Zhan YH; Zhang HH; Li Q; Wu B
    Asian Pac J Cancer Prev; 2014; 15(7):3045-50. PubMed ID: 24815445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways.
    Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L
    Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermal growth factor-like domain 7 promotes endothelial cell migration and angiogenesis by activating ERK signaling pathway].
    Cao Y; Lyu Q
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):270-3. PubMed ID: 25975912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of EGFL7 in human cancers: A review.
    de Oliveira C; Gonçalves PG; Bidinotto LT
    J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
    Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
    Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
    Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L
    Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
    Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D
    Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
    Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
    Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
    Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-126 and miR-126*: new players in cancer.
    Meister J; Schmidt MHH
    ScientificWorldJournal; 2010 Oct; 10():2090-100. PubMed ID: 20953557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
    Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
    Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell RNA sequencing reveals differential expression of EGFL7 and VEGF in giant-cell tumor of bone and osteosarcoma.
    Feleke M; Feng W; Song D; Li H; Rothzerg E; Wei Q; Kõks S; Wood D; Liu Y; Xu J
    Exp Biol Med (Maywood); 2022 Jul; 247(14):1214-1227. PubMed ID: 35695550
    [No Abstract]   [Full Text] [Related]  

  • 17. Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.
    d'Audigier C; Susen S; Blandinieres A; Mattot V; Saubamea B; Rossi E; Nevo N; Lecourt S; Guerin CL; Dizier B; Gendron N; Caetano B; Gaussem P; Soncin F; Smadja DM
    Stem Cell Rev Rep; 2018 Feb; 14(1):82-91. PubMed ID: 28980146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFL7 ligates αvβ3 integrin to enhance vessel formation.
    Nikolic I; Stankovic ND; Bicker F; Meister J; Braun H; Awwad K; Baumgart J; Simon K; Thal SC; Patra C; Harter PN; Plate KH; Engel FB; Dimmeler S; Eble JA; Mittelbronn M; Schäfer MK; Jungblut B; Chavakis E; Fleming I; Schmidt MHH
    Blood; 2013 Apr; 121(15):3041-50. PubMed ID: 23386126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFL7 enhances surface expression of integrin α
    Dudvarski Stanković N; Bicker F; Keller S; Jones DT; Harter PN; Kienzle A; Gillmann C; Arnold P; Golebiewska A; Keunen O; Giese A; von Deimling A; Bäuerle T; Niclou SP; Mittelbronn M; Ye W; Pfister SM; Schmidt MHH
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30065025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.